ECHURCH-USA Archives

The Electronic Church

ECHURCH-USA@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Vinny Samarco <[log in to unmask]>
Reply To:
The Electronic Church <[log in to unmask]>
Date:
Mon, 6 Aug 2012 22:22:49 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (156 lines)
Hi Everyone,
I know this may be somewhat off topic, however, If any of you suffer from 
this as I do, maybe you will be glad to see the clarity of this explanation.
God bless.
Vinny
----- Original Message ----- 
From: "Mary Lorefice" <[log in to unmask]>
To: "The Conduit" <[log in to unmask]>
Sent: Monday, August 06, 2012 6:41 PM
Subject: [The Conduit] Blind people more likely to suffer from 
light-relatedsleep disorder


Blind people more likely to suffer from light-related sleep disorder
Published on Monday August 06, 2012
Alyssa A. Botelho
The Washington Post

WASHINGTON-Melanie Brunson, who has been blind since birth, suddenly awoke
and found herself standing at 15th and K streets in Northwest Washington.

She had stopped at the corner on her way home from work to await a safe time
to cross and had dozed off. Even on awakening, she was so groggy she 
couldn't
focus well enough to hear passing cars and judge when it was safe to cross.
The incident was a startling reminder of the sleep problems that had plagued
her since birth.

"Who knows how long I had been standing there," she said. "I realized then
that my safety was in jeopardy, and I began searching for remedies with a
vengeance."

But years after that 2005 traffic scare and many subsequent visits to
doctors and sleep clinics, Brunson still lies awake in bed night after night
and then is desperately sleepy during the day.

Although doctors have not definitively identified her disorder, researchers
believe she suffers from non-24-hour sleep-wake disorder, or "non-24." The
chronic and little-known sleep condition is characterized by a body clock
that is not aligned with a 24-hour day.

Though non-24 can affect those with normal vision, it is especially
prevalent among blind people who cannot sense light, the strongest
environmental signal that synchronizes the brain's sleep-wake pattern to the
24-hour cycle of the Earth day.

According to the preliminary results of an ongoing clinical trial that were
released earlier this summer, of the estimated 65,000 to 95,000 blind people
in the United States who have sleep complaints, up to 70 per cent might
suffer from non-24.

"It is a devastating condition ... because you are trying to keep a job and
a social life while your body's internal clock is competing against the
24-hour outside world," said Harvard neuroscientist Steven Lockley, who is
one of the principal investigators of the clinical trial.

It was Lockley who told Brunson about non-24 at a meeting of the American
Council of the Blind (ACB).

"My boss at the time, who had been hearing about my sleep problems for
years, dragged me by the arm to Dr. Lockley and demanded, 'Fix her!'"
Brunson said.

With that introduction, Brunson, who is now the executive director of the
ACB, enrolled as a participant in one of Lockley's early studies on sleep
disorders of the blind. After working with his team, she learned that her
body clock ran on a cycle longer than 24 hours.

The human body clock consists of an intricate network of chemical and
electrical signals controlled by two rice-grain-size structures deep in the
brain. Most people's internal clock runs slightly longer than 24 hours.
However, among sighted people, the clock is reset each day by light-sensing
cells in the eyes that signal to the brain that it is daytime.

For the blind, this reset mechanism fails. The resulting symptoms are
similar to those experienced by sighted people who chronically disrupt their
light cycle by shift work or travel across time zones.

Here is how it works: In theory, a blind person with an internal body clock
of 24.5 hours may feel ready to fall asleep at 10:30 p.m. on Monday but not
be able to fall asleep until 11 p.m. on Tuesday. This cycle is unrelenting,
making those affected want to fall asleep later and later each day.

For Brunson, the waves of disturbed sleep typically occur in three- or
four-week episodes of insomnia that cause her to wake up between 1 and 2 in
the morning, regardless of when she goes to bed.

Jack Mendez, a 35-year-old information technology professional who learned
last year that he has non-24, often finds himself awaking between 2 a.m. and
5:30 a.m., unable to fall back to sleep. On the evening that he spoke with a
Post reporter, he had been awake since 3 in the morning.

Some who suffer from non-24 have found limited relief through treatment with
synthetic versions of the hormone melatonin, which works to drag forward the
body clock's reset time by providing a chemical pulse to the brain that
signals nighttime.

Synthetic doses of melatonin help alleviate Brunson's non-24, but the
treatment does not work at all for Mendez.

"It gives me nightmares and cold sweats, and I feel hung over the next day,"
he said.

Shuttled from doctor to doctor as a child, Mendez has been prescribed
everything from sleeping pills to psychotropic drugs. Thus far, he has found
no treatments that help. He praises his fiancée for her patience in
tolerating their often opposite sleeping schedules.

There are no FDA-approved medications to treat non-24. However, the ongoing
clinical trial has advanced from screening participants for non-24 to
testing a candidate drug called tasimelteon. The drug, which is intended to
treat non-24 and other circadian rhythm sleep disorders, is being developed
by Washington, D.C.,-based Vanda Pharmaceuticals.

Vanda scientists hope that tasimelteon, which has a similar molecular
structure to melatonin, will have superior beneficial effects. Synthetic
melatonin itself is classified as a dietary supplement.

Northwestern University professor Phyllis Zee, a neuroscientist and sleep
specialist who was not involved in Vanda's research, said that tasimelteon's
long-term effects remain unclear, but at the very least the trial is
valuable in raising awareness about and creating a better understanding of
the condition.

"Most physicians and blind patients are unfamiliar with non-24, and a
large-scale study of the totally blind is crucial in developing criteria for
diagnosis," she said.

Although Brunson and Mendez both participated in the screening phase of the
tasimelteon trial, neither of them chose to take the drug because they were
wary of its impact on job performance and its interactions with other
medications.

But Mendez, who is at the Louisiana Center for the Blind finishing a
nine-month training program that will help him travel and work more
independently, plans to rejoin the trial and try tasimelteon after his
course ends.

"The training has helped me learn to think about blindness as just a
characteristic, not as a thing that consumes my life," he said. "Of course,
a good sleep helps with that thinking, too."
MaryL


To unsubscribe from The Conduit list, simply copy the line below.  Paste it 
in the to line of a blank message and send it. Follow the directions in the 
confirm message.
[log in to unmask]
To post to the list send the message to.
[log in to unmask]
Note: In an effort to help control SPAM this list will reject any message 
that contains
other addresses, either in the CC or BCC line.
No warnings are to be posted to this list unless approved by VIP Conduit 
first. 

ATOM RSS1 RSS2